CytomX Therapeutics, Inc. — Cash Flow Charts

8 quarters of history · ending 2025-12-31 · SEC EDGAR

Income Statement Cash Flow Balance Sheet Key Metrics

Source:10-K · 10-Q

Capital Allocation

How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).

Capital Allocation Waterfall

Buybacks vs Stock-Based Comp

Capex↑+151.3% +$121K

$201K